Synopsis of recent research by authors named "Xiangru Lu"
- Xiangru Lu's recent research primarily focuses on the therapeutic potential of annexin A5 in mitigating severe COVID-19 symptoms and endothelial inflammation, highlighting its anti-inflammatory, anticoagulant, and anti-apoptotic properties through various clinical trials and preclinical studies.
- The author has explored the molecular mechanisms underlying congenital heart defects, addressing the impacts of maternal factors such as pregestational diabetes and cannabis exposure on fetal heart development, and investigated protective strategies like exercise and pharmacological interventions to reduce these risks.
- Lu's work on the role of reactive oxygen species and signaling pathways in cardiac development and injury is evident in studies examining Rac1 signaling, NOX2 involvement, and the effects of nitric oxide synthase, contributing valuable insights into cardiac regeneration and the pathology of congenital heart defects.
